Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR Part 330, Subpart B—Administrative Procedures
21 CFR Part 330, Subpart B—Administrative Procedures, “Administrative Procedures”, is a CFR division of 21 CFR Part 330—Over-the-counter (OTC) human drugs which are generally recognized as safe and effective and not misbranded.
https://ontology.bommaritollc.com/id/01a0f094-b5ff-7515-b033-d203cc5fd360
Elsewhere
Facts
| adms:identifier | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR Part 330, Subpart B |
| schema:legislationJurisdiction | |
| schema:legislationType | |
| schema:name | Administrative Proceduresen |
| skos:prefLabel | 21 CFR Part 330, Subpart B—Administrative Proceduresen |
Related
Parts (6)schema:isPartOf
- 21 CFR 330.10 Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs.
- 21 CFR 330.11 NDA deviations from applicable monograph.
- 21 CFR 330.12 Status of over-the-counter (OTC) drugs previously reviewed under the Drug Efficacy Study (DESI).
- 21 CFR 330.13 Conditions for marketing ingredients recommended for over-the-counter (OTC) use under the OTC drug review.
- 21 CFR 330.14 Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded.
- 21 CFR 330.15 Timelines for FDA review and action on time and extent applications and safety and effectiveness data submissions.